PLX Protalix BioTherapeutics Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Protalix BioTherapeutics Inc. market cap is $115.25M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Protalix BioTherapeutics Inc. 52 week high is $3.55 as of September 29, 2023.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Protalix BioTherapeutics Inc. 52 week low is $1.00 as of September 29, 2023.

Protalix BioTherapeutics Inc. stock price today is $1.61.

Protalix BioTherapeutics Inc. stock price yesterday was $1.70.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Protalix BioTherapeutics Inc.’s P/E ratio is 133.06.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Protalix BioTherapeutics Inc. P/B ratio is 2.9549.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Protalix BioTherapeutics Inc.'s EBITDA is 10.71.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Protalix BioTherapeutics Inc. 50-day moving average is $1.79.

Protalix BioTherapeutics Inc. has 197 employees.